Login to Your Account



OSI, Lilly Sign Potential $385M Deal For GKA Drugs In Diabetes

By Jennifer Boggs


Monday, January 8, 2007
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription